Immunovant, Inc.

IMVT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$521,870$598,912$713,971$374,685
Short-Term Investments$0$0$0$0
Receivables$1,970$1,936$2,511$2,224
Inventory$0$0$0$0
Other Curr. Assets$49,706$50,915$51,180$35,632
Total Curr. Assets$573,546$651,763$767,662$412,541
Property Plant & Equip (Net)$632$737$942$774
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$8,781$8,940$7,618$7,617
Total NC Assets$9,413$9,677$8,560$8,391
Other Assets$0$0$0$0
Total Assets$582,959$661,440$776,222$420,932
Liabilities
Payables$6,916$7,843$17,656$19,816
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$56,338$39,076$15,618$11,253
Total Curr. Liab.$63,254$52,900$68,775$68,315
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$0$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$98$23
Total Liabilities$63,254$52,900$68,775$68,315
Equity
Pref Stock$0$0$0$0
Common Stock$17$16$16$14
Retained Earnings-$1,486,638-$1,360,136-$1,239,523-$1,133,074
AOCI$1,450$1,737$1,459$2,479
Other Equity$0$0$0$0
Total Equity$519,705$608,540$707,447$352,617
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$582,959$661,440$776,222$420,932
Net Debt-$521,870-$598,912-$713,971-$374,685
Immunovant, Inc. (IMVT) Financial Statements & Key Stats | AlphaPilot